Learn More

Advanced Technology

A spin-off from astrophysics research, our patented, breakthrough monochromatic x-ray mammography instrument offers an unprecedented combination of sensitivity, spatial resolution, low-dose, and ease of use.

Early Detection

It promises to overcome many of the problems with the detection of cancerous lesions in dense breasts. This 2-D and 3-D diagnostic tool will serve a very large group of women (30-50%) who go undiagnosed and who are most at risk for developing breast cancer.

Less Radiation

It will reduce screening doses by more than a factor of 20 for ALL women, allowing annual exams that substantially reduce lifetime radiation exposure.

Widespread Use

Instruments incorporating this technology will cost no more to produce than units currently used in breast care clinics.

team

Eric Silver, Ph. D.

CEO

Among other inventions, conceived, patented and built the prototype monochromatic x-ray system.

Valerie Carter, Esq.

Advisor

Founding partner of Carter & Doyle, LLP

Doug Fisher, MD

Board Member / Advisor

Partner at InterWest Partners

Neil S. Fruman, MD

Advisor

Family practitioner, John Muir Medical Group, Walnut Creek, CA.

Elsie Levin, MD

Advisor

Medical Director of Boston Breast Diagnostic Center

Tejas Shirish Mehta, MD

Advisor

Chief of Breast Imaging and Co-Director of the BreastCare Center at Beth Israel Deaconess in Boston, MA.

Alexander Norbash, MD

Advisor

Professor and Chair of Radiology, Boston University and Boston Medical Center

Abram Recht, MD

Advisor

Professor of Radiation Oncology at Harvard Medical School and Deputy Chief, Dept of Radiation Oncology at Beth Israel Deaconess

Seth Shulman, Ph.D

Advisor

Expert in radiation physics, biomedical engineering and molecular imaging and was the founder of Bioscan, Inc.

Sam Zucker, Esq.

Advisor

Partner at Sidley Austin, LLP